Free Trial
NASDAQ:GOCO

GoHealth (GOCO) Stock Price, News & Analysis

$7.62
-0.44 (-5.46%)
(As of 09/6/2024 ET)
Today's Range
$7.41
$7.98
50-Day Range
$7.42
$14.57
52-Week Range
$7.27
$16.50
Volume
16,354 shs
Average Volume
18,063 shs
Market Capitalization
$173.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00

GoHealth MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
70.6% Upside
$13.00 Price Target
Short Interest
Healthy
2.46% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.50mentions of GoHealth in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($5.35) to ($4.31) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.11 out of 5 stars

Finance Sector

618th out of 871 stocks

Insurance Agents, Brokers, & Service Industry

13th out of 21 stocks

GOCO stock logo

About GoHealth Stock (NASDAQ:GOCO)

GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. It provides Medicare plans, including Medicare Advantage, Medicare Supplement and Prescription Drug, and Medicare Special Needs Plans. The company also offers partner marketing services. It sells its products through carriers and online platform, as well as independent and external agencies. The company was founded in 2001 and is headquartered in Chicago, Illinois.

GOCO Stock Price History

GOCO Stock News Headlines

Ex-CIA Advisor: “This is How Kamala will Rig the Election”
A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…
GoHealth A earnings: here's what to expect
Ex-CIA Advisor: “This is How Kamala will Rig the Election”
A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…
GoHealth Reports Second Quarter 2024 Results
GoHealth Announces Changes to Board of Directors
GoHealth, Inc Q1 Loss Misses Estimates
See More Headlines
Receive GOCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GoHealth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/08/2024
Today
9/07/2024
Next Earnings (Estimated)
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Insurance agents, brokers, & service
Sub-Industry
Insurance
Current Symbol
NASDAQ:GOCO
Fax
N/A
Employees
2,530
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.00
High Stock Price Target
$13.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+70.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-63,260,000.00
Pretax Margin
-19.85%

Debt

Sales & Book Value

Annual Sales
$700.20 million
Cash Flow
$2.69 per share
Book Value
$14.35 per share

Miscellaneous

Free Float
14,771,000
Market Cap
$173.19 million
Optionable
Not Optionable
Beta
1.70
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives


GOCO Stock Analysis - Frequently Asked Questions

How have GOCO shares performed this year?

GoHealth's stock was trading at $13.34 at the beginning of the year. Since then, GOCO shares have decreased by 42.9% and is now trading at $7.62.
View the best growth stocks for 2024 here
.

How were GoHealth's earnings last quarter?

GoHealth, Inc. (NASDAQ:GOCO) issued its earnings results on Thursday, August, 8th. The company reported ($0.75) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.47) by $1.72. The company earned $105.87 million during the quarter, compared to the consensus estimate of $138.99 million. GoHealth had a negative trailing twelve-month return on equity of 8.51% and a negative net margin of 8.62%.

What is Matthew Crummack's approval rating as GoHealth's CEO?

25 employees have rated GoHealth Chief Executive Officer Matthew Crummack on Glassdoor.com. Matthew Crummack has an approval rating of 90% among the company's employees.

When did GoHealth IPO?

GoHealth (GOCO) raised $750 million in an initial public offering on Wednesday, July 15th 2020. The company issued 39,500,000 shares at $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.

Who are GoHealth's major shareholders?

GoHealth's top institutional investors include Renaissance Technologies LLC (0.08%) and Bank of New York Mellon Corp (0.06%). Insiders that own company stock include Cayman Gp Ltd Ccp III, Blizzard Holdings C LP Cb, Vijay Kotte and Jason Schulz.
View institutional ownership trends
.

How do I buy shares of GoHealth?

Shares of GOCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of GoHealth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that GoHealth investors own include Tesla (TSLA), Alibaba Group (BABA), CVS Health (CVS), Moderna (MRNA), RTX (RTX) and Walmart (WMT).

This page (NASDAQ:GOCO) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners